|
Market Closed -
TEL AVIV STOCK EXCHANGE
13:44:01 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 113.20 ILa | -0.18% |
|
-5.11% | -62.34% |
| 10-06 | Evogene Enters into Cooperation Agreement with L.I.A. Pure Capital | CI |
| 10-06 | Evogene Ltd. Announces Appointment of Pure Capital Group Nominee Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.76M | - | - | - | ||
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
- Stock Market
- Stocks
- EVGN Stock
- Charts Evogene Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
